Skip to content
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: September 13, 2024

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More
Page1 Page2 Page3 Page4 Page5
RECENT POSTS

Dr. Rasha Kelej, CEO of Merck Foundation, Leverages Creativity to Combat Infertility Stigma and Support Girl Education

June 30, 2026

Africa CDC Urgently Seeks US$18 Million to Fund Critical Ebola Research

June 30, 2026

Pakistan Airstrikes in Afghanistan Result in Civilian Casualties

June 29, 2026

Africa CDC and WHO Unveil Joint Platform for Ebola Response

June 29, 2026

Thousands of Foreign Nationals Flee South Africa as Anti-Immigrant Protests Intensify

June 29, 2026

Rwandan Foreign Minister Criticizes US Mediation in DR Congo Conflict

June 29, 2026

EU Expresses Deep Concern Over Human Rights Violations in Eastern DRC

June 29, 2026

UN Commission Warns of Grave Human Rights Situation in Eastern Democratic Republic of the Congo

June 29, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.